22 September 2017 : Original article
Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA)
DOI: 10.12659/AOT.905649
Ann Transplant 2017; 22:570-574
HTML version available soon